A detailed history of George Soros (Soros Fund Management LLC) transactions in Exact Sciences Corp stock. As of the latest transaction made, Soros Fund Management LLC holds 225,000 shares of EXAS stock, worth $12.3 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
225,000
Holding current value
$12.3 Million
% of portfolio
0.23%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$41.33 - $74.26 $9.3 Million - $16.7 Million
225,000 New
225,000 $9.51 Million
Q2 2020

Aug 14, 2020

SELL
$55.75 - $92.75 $462,725 - $769,825
-8,300 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$37.9 - $104.44 $314,570 - $866,852
8,300 New
8,300 $481,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.68B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track George Soros's Portfolio

Track George Soros Portfolio

Follow George Soros (Soros Fund Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soros Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Soros Fund Management LLC and George Soros with notifications on news.